Skip to content
Maui Sky – Lifestyle
Author:
Cytonics Corporation
Cytonics Uses Ten Years of Osteoarthritis Natural-History Data to Shape the Next Stage of CYT-108 Clinical Development
November 18, 2026
Cytonics Completes $4.8 Million Gross-Proceeds Financing Campaign
September 9, 2026
Cytonics Completes First-In-Human Phase 1 Clinical Study Report for CYT-108, Advancing Program Toward Next Phase of Development.
June 30, 2026